Would you want to know if your unborn baby is at risk of autism? Researchers wrapping up a 4,406-patient study say that a new genetic test that analyzes fetal DNA in more detail than current prenatal ...

A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...

Noninvasive prenatal screening, involving analysis of fetal cell-free DNA in maternal blood, is currently available only for a small number of conditions caused by large chromosomal abnormalities.

A DNA test of a pregnant woman’s blood is more accurate than current methods of screening for Down syndrome and other common disorders, new research finds. If other studies bear this out, it could ...

Myriad Genetics (MYGN) continues to empower parents with increased access to prenatal testing. SneakPeek is now available over the counter in more than 8,800 retail locations nationwide. The product ...

Advances in modern medicine allow us to treat fetuses and newborn babies for genetic or inherited diseases. Advances in modern medicine allow us to treat fetuses and newborn babies for genetic or ...

In the past, parents-to-be concerned with the genetic state of their gestating offspring had to test both the mother’s and father’s blood in order to determine what traits the child would likely ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save ...

SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwide SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, ...

SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to ...